Concourse Financial Group Securities’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,750
Closed -$9.44K 2304
2024
Q3
$12.5K Buy
1,750
+250
+17% +$1.78K ﹤0.01% 1632
2024
Q2
$11K Buy
1,500
+500
+50% +$4.36K ﹤0.01% 1665
2024
Q1
$10K Buy
1,000
+900
+900% +$7.88K ﹤0.01% 1703
2023
Q4
$701 Hold
100
﹤0.01% 2152
2023
Q3
$794 Hold
100
﹤0.01% 2127
2023
Q2
$554 Hold
100
﹤0.01% 2219
2023
Q1
$569 Hold
100
﹤0.01% 2239
2022
Q4
$699 Buy
+100
New +$1.03K ﹤0.01% 2212
2022
Q3
Sell
-1,125
Closed -$13K 2194
2022
Q2
$12K Sell
1,125
-325
-22% -$4.83K ﹤0.01% 1609
2022
Q1
$30K Buy
1,450
+500
+53% +$10.9K ﹤0.01% 1340
2021
Q4
$24K Buy
950
+750
+375% +$20.7K ﹤0.01% 1577
2021
Q3
$6K Buy
+200
New +$6.93K ﹤0.01% 2036

Other funds holding MSOS

Concourse Financial Group Securities's MSOS Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2024, closing a stake of 1,750 shares — an estimated $9.44K sold.

Concourse Financial Group Securities first reported a position in MSOS in Q3 2021 and held it in 12 quarters. The position peaked at $30K in Q1 2022. 178 funds tracked by Wall St. Rank hold MSOS as of Q4 2024.

  • Concourse Financial Group Securities reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,750 AdvisorShares Pure US Cannabis ETF shares in Q4 2024, an estimated $9.44K.
  • Concourse Financial Group Securities first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2021 and held it in 12 quarters.
  • Concourse Financial Group Securities's AdvisorShares Pure US Cannabis ETF position peaked at $30K in Q1 2022.
  • 178 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.